04/24/2023
In recent years, psychedelics have been researched as therapeutics for a diverse and expanding group of conditions including, but not limited to, depression, anxiety, OCD, PTSD, cluster headaches, substance use disorders, and even anorexia nervosa. Additionally, psychedelics are being explored as treatment options for comorbidities such as depression associated with cancer or Alzheimer’s disease.
One of these psychedelic therapies involves ketamine, traditionally utilized as an anesthetic, in the treatment of specific psychiatric conditions.
To learn about the uses of psychedelic therapies and the hurdles involved in incorporating them into clinical practice, read on here: https://www.mdlinx.com/article/psychedelics-are-on-their-way-to-fda-approval-are-we-ready/5lXUlhp4iz5OrjYB4oFydP
This article explores the growing interest in using psychedelics for medical purposes, the FDA approval process, and the challenges of integrating these drugs into clinical practice.